The increasing adoption of personalized medicine and rising investments in healthcare research and development are driving the growth of the CRO Mass Spectroscopy Services Market. Additionally, the growing demand for advanced analytical techniques in drug discovery and development is fueling the market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Service Type, End Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Alturas Analytics, BGI Group, Charles River Laboratories International Inc, Creative Proteomics, Evotec SE, Inotiv, Bioanalytical Systems, Labcorp Drug Development, MtoZ-Biolabs, PPD, WuXi AppTec, Eurofins Scientific, MS Bioworks, Novatia LLC, Alphalyse, Metabolon, Biocrates life sciences AG, Biognosys, Proteome Sciences, Rapid Novor Inc, iBET, BioCAT, Olink, AxisPharm, MtoZ-Biolabs Inc, Somalogic Inc, Seer |
The stringent regulatory requirements and high costs associated with mass spectrometry services are major restraints hindering the growth of the market. Moreover, the lack of skilled professionals in the field of mass spectrometry is also impeding market growth.